Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
International
EFPIA Files Complaint Against French Law Promoting Off-Label Avastin Use
Earlier this week, EFPIA, Europe's pharmaceutical industry association, announced it had filed a complaint with the…
UK Health Secretary Announces Mandatory “Sunshine Rule” After…
Yesterday, British Health Secretary Jeremy Hunt announced that all National Health Service hospitals and General…
Undercover Report on Industry Relationship With NHS Inspires Discussion For…
Last week, Telegraph UK published a number of articles based on undercover interviews that targeted the relationships between drug…
Iceland Adopts EFPIA Disclosure Code
Polaris has reported that Frumtök, the Icelandic Association of the Pharmaceutical Industry, has adopted the EFPIA…
Transparency International Addresses “Corruption in the Pharmaceuticals and…
At this year’s International Pharmaceutical Compliance Congress and Best Practices Forum, Robert Barrington, the Executive…
The Fifth Asia-Pacific Pharmaceutical Compliance Congress and Best…
The Fifth Asia-Pacific Pharmaceutical Compliance Congress and Best Practices Forum will be held on August 17-18, 2015 in…
Update on French Sunshine Law
The Sunshine Act in the United States is but one physician payment disclosure obligation for manufacturers of drugs and…
New Medicines Australia Code Tightens Transparency Provisions
On April 24, 2015, the Australian Competition Consumer Commission (ACCC) granted authorization of Edition 18 of the industry trade…
New Zealand Transparency Advocates Call For Sunshine Act
A group of transparency advocates in New Zealand has been writing various articles on the value of “more Sunshine” for a…
International Pharmaceutical Compliance Congress and Best Practices Forum:…
The ninth International Pharmaceutical Compliance Congress and Best Practices Forum is returning to Brussels, where the first was…